Guozhong Ji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Guozhong Ji has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Lin Miao
Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
7 shared publications - Xiuhua Zhang
Department of Gastroenterology, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China
5 shared publications Zuhong Ji
Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
5 shared publications- Fatema Tabak
Institute of Digestive Endoscopy and Medical Center for Digestive Disease Second Affiliated Hospital of Nanjing Medical University 210011 Nanjing Jiangsu Province China
4 shared publications Lei Liu
Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
4 shared publicationsLinlin Yin
Nanjing University of Chinese Medicine
4 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1912393
Integrative transcriptomic and experimental analyses prioritize TPT1 as a PANoptosis-associated candidate molecular marker in sarcopenia
Background: Sarcopenia lacks sensitive molecular markers for early detection, and its relationship with integrated inflammatory cell-death programs remains unclear. PANoptosis integrates apoptotic, pyroptotic, and necroptotic signaling and therefore provides a plausible framework for investigating inflammatory-stress remodeling in aging skeletal muscle. Methods: We integrated four bulk-transcriptomic datasets from the Gene Expression Omnibus into a training cohort (66 controls; 37 sarcopenia) and used GSE111016 as an external validation cohort (20 controls; 20 sarcopenia). We intersected differentially expressed genes with a curated PANoptosis-associated gene set and then performed enrichment analysis; least absolute shrinkage and selection operator (LASSO), random forest and extreme gradient boosting (XGBoost) feature selection; nomogram and receiver operating characteristic (ROC) analyses; CIBERSORT immune-cell deconvolution; and single-nucleus RNA sequencing (snRNA-seq) reanalysis. We assessed tumor protein, translationally controlled 1 (TPT1) expression in D-galactose-treated mouse and C2C12 models. Results: Among 608 differentially expressed genes, 47 overlapped with the curated PANoptosis-associated gene set. These genes were enriched in apoptotic signaling; cytokine, nuclear factor kappa B (NF-κB), tumor necrosis factor (TNF), and nucleotide-binding oligomerization domain (NOD)-like receptor pathways; regulated necrosis; extracellular-matrix remodeling; and impaired oxidative phosphorylation. Three machine-learning algorithms converged on neurotrophic receptor tyrosine kinase 1 (NTRK1), TPT1, and TNF receptor-associated protein 1 (TRAP1). TPT1 showed the strongest single-gene discrimination, with areas under the ROC curve of 0.819 (95% confidence interval [CI], 0.737–0.900) in the training cohort and 0.753 (95% CI, 0.598–0.907) in the external cohort. Immune-cell deconvolution linked the candidate genes to estimated mast-cell, plasma-cell, cluster of differentiation 8-positive (CD8 + ) T-cell, and macrophage proportions. Single-nucleus analysis of 97,154 nuclei from 17 donors showed broad TPT1 expression across myonuclear, satellite-cell, stromal, endothelial, and immune compartments, with lower expression in older muscle. Network and gene set variation analyses associated lower TPT1 expression with inflammatory, oxidative-stress, cell-death, and stress-adaptive pathways. In D-galactose-treated mice and C2C12 myotubes, muscle-wasting or senescence-like changes coincided with lower TPT1 protein abundance. Conclusion: This study prioritizes TPT1 as a candidate molecular marker associated with the bulk-transcriptomic sarcopenia phenotype. The aging-muscle and D-galactose analyses provide biological context but do not establish sarcopenia specificity or causality. Prospective clinical validation and functional perturbation studies are required.
- 20 August 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1912393
Open AccessIntegrative transcriptomic and experimental analyses prioritize TPT1 as a PANoptosis-associated candidate molecular marker in sarcopenia
Background: Sarcopenia lacks sensitive molecular markers for early detection, and its relationship with integrated inflammatory cell-death programs remains unclear. PANoptosis integrates apoptotic, pyroptotic, and necroptotic signaling and therefore provides a plausible framework for investigating inflammatory-stress remodeling in aging skeletal muscle. Methods: We integrated four bulk-transcriptomic datasets from the Gene Expression Omnibus into a training cohort (66 controls; 37 sarcopenia) and used GSE111016 as an external validation cohort (20 controls; 20 sarcopenia). We intersected differentially expressed genes with a curated PANoptosis-associated gene set and then performed enrichment analysis; least absolute shrinkage and selection operator (LASSO), random forest and extreme gradient boosting (XGBoost) feature selection; nomogram and receiver operating characteristic (ROC) analyses; CIBERSORT immune-cell deconvolution; and single-nucleus RNA sequencing (snRNA-seq) reanalysis. We assessed tumor protein, translationally controlled 1 (TPT1) expression in D-galactose-treated mouse and C2C12 models. Results: Among 608 differentially expressed genes, 47 overlapped with the curated PANoptosis-associated gene set. These genes were enriched in apoptotic signaling; cytokine, nuclear factor kappa B (NF-κB), tumor necrosis factor (TNF), and nucleotide-binding oligomerization domain (NOD)-like receptor pathways; regulated necrosis; extracellular-matrix remodeling; and impaired oxidative phosphorylation. Three machine-learning algorithms converged on neurotrophic receptor tyrosine kinase 1 (NTRK1), TPT1, and TNF receptor-associated protein 1 (TRAP1). TPT1 showed the strongest single-gene discrimination, with areas under the ROC curve of 0.819 (95% confidence interval [CI], 0.737–0.900) in the training cohort and 0.753 (95% CI, 0.598–0.907) in the external cohort. Immune-cell deconvolution linked the candidate genes to estimated mast-cell, plasma-cell, cluster of differentiation 8-positive (CD8 + ) T-cell, and macrophage proportions. Single-nucleus analysis of 97,154 nuclei from 17 donors showed broad TPT1 expression across myonuclear, satellite-cell, stromal, endothelial, and immune compartments, with lower expression in older muscle. Network and gene set variation analyses associated lower TPT1 expression with inflammatory, oxidative-stress, cell-death, and stress-adaptive pathways. In D-galactose-treated mice and C2C12 myotubes, muscle-wasting or senescence-like changes coincided with lower TPT1 protein abundance. Conclusion: This study prioritizes TPT1 as a candidate molecular marker associated with the bulk-transcriptomic sarcopenia phenotype. The aging-muscle and D-galactose analyses provide biological context but do not establish sarcopenia specificity or causality. Prospective clinical validation and functional perturbation studies are required.
- Open Access
- 21 July 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Associations of abnormal blood lipid levels with hospitalization cost and disease severity in patients with hyperlipidemic pancreatitis: a retrospective cohort study
Background: Hyperlipidemic pancreatitis (HLP) carries a considerable clinical and economic burden. This retrospective study examined how abnormal blood lipid levels relate to hospitalization cost and disease severity in patients with HLP, with the aim of informing risk stratification and lipid management in clinical practice. Methods: We retrospectively reviewed 117 patients with HLP accounting for 171 hospitalizations at Jen Ching Memorial Hospital between January 2018 and June 2025. Total hospitalization cost (THC) was analyzed by gamma regression and length of stay (LOS) by negative binomial regression, with cluster-robust standard errors to account for repeated hospitalizations in the same patient. Results: At the first hospitalization, the median triglyceride (TG) level was 13.56 mmol/L and the median total cholesterol (TC) level was 8.89 mmol/L. The median LOS was 6 days and the median THC was 10,920.44 yuan (US$1,528.85). In multivariable analyses, both lipids were positively associated with THC. Each 1 mmol/L increase in TG corresponded to a 2.2% higher THC (approximately 240 yuan; US$33.60) (rate ratio [RR] = 1.022, 95% confidence interval [CI] = 1.008–1.040, P = 0.013). Each 1 mmol/L increase in TC corresponded to a 5.3% higher THC (approximately 580 yuan; US$81.20) (RR = 1.053, 95% CI = 1.004–1.098, P = 0.046). Higher TG levels were further associated with greater odds of intensive care unit (ICU) transfer and complications. Conclusion: Higher TG and TC levels were associated with greater hospitalization cost, and higher TG levels with severity-related indicators. These associations suggest that lipid levels may be useful for risk stratification in patients with HLP.
- 21 July 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessAssociations of abnormal blood lipid levels with hospitalization cost and disease severity in patients with hyperlipidemic pancreatitis: a retrospective cohort study
Background: Hyperlipidemic pancreatitis (HLP) carries a considerable clinical and economic burden. This retrospective study examined how abnormal blood lipid levels relate to hospitalization cost and disease severity in patients with HLP, with the aim of informing risk stratification and lipid management in clinical practice. Methods: We retrospectively reviewed 117 patients with HLP accounting for 171 hospitalizations at Jen Ching Memorial Hospital between January 2018 and June 2025. Total hospitalization cost (THC) was analyzed by gamma regression and length of stay (LOS) by negative binomial regression, with cluster-robust standard errors to account for repeated hospitalizations in the same patient. Results: At the first hospitalization, the median triglyceride (TG) level was 13.56 mmol/L and the median total cholesterol (TC) level was 8.89 mmol/L. The median LOS was 6 days and the median THC was 10,920.44 yuan (US$1,528.85). In multivariable analyses, both lipids were positively associated with THC. Each 1 mmol/L increase in TG corresponded to a 2.2% higher THC (approximately 240 yuan; US$33.60) (rate ratio [RR] = 1.022, 95% confidence interval [CI] = 1.008–1.040, P = 0.013). Each 1 mmol/L increase in TC corresponded to a 5.3% higher THC (approximately 580 yuan; US$81.20) (RR = 1.053, 95% CI = 1.004–1.098, P = 0.046). Higher TG levels were further associated with greater odds of intensive care unit (ICU) transfer and complications. Conclusion: Higher TG and TC levels were associated with greater hospitalization cost, and higher TG levels with severity-related indicators. These associations suggest that lipid levels may be useful for risk stratification in patients with HLP.
- 17 July 2026
- Published by Elsevier in Molecular Immunology
- Vol. 197, 34-45
SIRT1/NRF2 axis regulates NLRP3-mediated macrophage inflammation and renal injury in hypertension with hyperuricemia
- 17 July 2026
- Published by Elsevier in Molecular Immunology
- Vol. 197, 34-45
SIRT1/NRF2 axis regulates NLRP3-mediated macrophage inflammation and renal injury in hypertension with hyperuricemia
- Open Access
- 29 June 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1876261
Association of serum 25-hydroxyvitamin D levels with indicators of target organ damage in patients with diabetes: a cross-sectional study
Objective: To assess serum 25-hydroxyvitamin D [25(OH)D] in relation to indicators of target organ damage in patients with diabetes. Methods: This analysis included 372 adults with diabetes who underwent serum 25(OH)D testing in the Department of Endocrinology at Jen Ching Memorial Hospital from January 1 to December 31, 2025. Data on demographic characteristics, medical history, laboratory parameters, carotid ultrasonography, and electrophysiological examinations were collected. We performed multivariable regression models to examine the associations of serum 25(OH)D levels with peripheral nerve dysfunction, carotid plaque, urinary microalbumin (mALB), cerebral infarction, and coronary heart disease (CHD). Restricted cubic spline (RCS), threshold effect, and sensitivity analyses were further employed. Results: Serum 25(OH)D was inversely associated with peripheral nerve damage and carotid plaque. After adjustment for all prespecified covariates, the corresponding odds ratios were 0.941 (95% CI , 0.905–0.976; P = 0.001) and 0.942 (95% CI , 0.906–0.977; P = 0.002), respectively. Serum 25(OH)D levels were also inversely associated with log-transformed mALB ( β = -0.035, 95% CI , -0.057 to -0.013; P = 0.002). In continuous-variable models, higher serum 25(OH)D was additionally associated with lower odds of cerebral infarction ( OR = 0.896, 95% CI , 0.816–0.971; P = 0.013) and CHD ( OR = 0.902, 95% CI , 0.835–0.966; P = 0.006) after full adjustment. RCS and exploratory threshold analyses suggested nonlinear associations of serum 25(OH)D with peripheral nerve damage and mALB. Sensitivity analyses yielded consistent results. Conclusions: Among patients with diabetes, lower serum 25(OH)D levels were associated with peripheral nerve damage, carotid plaque, and higher mALB levels. These findings support an association between serum 25(OH)D and indicators of diabetes-related target organ damage, but prospective studies are needed to clarify the temporal and clinical significance of these associations.
- 29 June 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1876261
Open AccessAssociation of serum 25-hydroxyvitamin D levels with indicators of target organ damage in patients with diabetes: a cross-sectional study
Objective: To assess serum 25-hydroxyvitamin D [25(OH)D] in relation to indicators of target organ damage in patients with diabetes. Methods: This analysis included 372 adults with diabetes who underwent serum 25(OH)D testing in the Department of Endocrinology at Jen Ching Memorial Hospital from January 1 to December 31, 2025. Data on demographic characteristics, medical history, laboratory parameters, carotid ultrasonography, and electrophysiological examinations were collected. We performed multivariable regression models to examine the associations of serum 25(OH)D levels with peripheral nerve dysfunction, carotid plaque, urinary microalbumin (mALB), cerebral infarction, and coronary heart disease (CHD). Restricted cubic spline (RCS), threshold effect, and sensitivity analyses were further employed. Results: Serum 25(OH)D was inversely associated with peripheral nerve damage and carotid plaque. After adjustment for all prespecified covariates, the corresponding odds ratios were 0.941 (95% CI , 0.905–0.976; P = 0.001) and 0.942 (95% CI , 0.906–0.977; P = 0.002), respectively. Serum 25(OH)D levels were also inversely associated with log-transformed mALB ( β = -0.035, 95% CI , -0.057 to -0.013; P = 0.002). In continuous-variable models, higher serum 25(OH)D was additionally associated with lower odds of cerebral infarction ( OR = 0.896, 95% CI , 0.816–0.971; P = 0.013) and CHD ( OR = 0.902, 95% CI , 0.835–0.966; P = 0.006) after full adjustment. RCS and exploratory threshold analyses suggested nonlinear associations of serum 25(OH)D with peripheral nerve damage and mALB. Sensitivity analyses yielded consistent results. Conclusions: Among patients with diabetes, lower serum 25(OH)D levels were associated with peripheral nerve damage, carotid plaque, and higher mALB levels. These findings support an association between serum 25(OH)D and indicators of diabetes-related target organ damage, but prospective studies are needed to clarify the temporal and clinical significance of these associations.
- Open Access
- 5 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (23) , e49181
Analysis of ultrasound quality control in primary healthcare institutions: A cross-sectional study from Jiangsu Province, China
Ultrasound is integral to modern clinical care, but primary healthcare institutions often face equipment, staffing, and quality-control challenges that produce inconsistent imaging and undermine diagnostic reliability. This study evaluated interregional differences in ultrasound quality control across Jiangsu Province to inform resource allocation and policy. This study aimed to analyze the current status of ultrasound quality control in primary healthcare institutions across different regions of Jiangsu Province. We conducted province-wide ultrasound quality-control management using a targeted electronic instrument, The Jiangsu Provincial Survey Questionnaire on Ultrasound Medical Quality Control in Primary Healthcare Institutions. A random sample of 61 primary-care ultrasound departments was surveyed. Seven indicators were analyzed: staffing, number of ultrasound examinations, physician-to-patient ratio, ratio of ultrasound physicians to diagnostic devices, number of critical-value notifications, positive rate of ultrasound reports, and diagnostic concordance rate. Between-group comparisons employed 1-way analysis of variance or Kruskal–Wallis tests according to normality and variance homogeneity; categorical variables were compared using χ 2 tests, with significance at.05. No statistically significant regional differences were observed for the number of ultrasound physicians, number of sonographers (technologists), sonographers’ educational attainment, the ratio of physicians to ultrasound diagnostic devices, or the positive rate of ultrasound reports. Significant differences were found for physicians’ educational attainment ( χ 2 = 13.554, P = .006) and for annual number of examinations ( F = 3.171, P = .049). Significant regional differences in physician-to-patient ratio, number of critical-value notifications, and diagnostic concordance rate ( H = 6.982, 8.170 and 7.061; P = .030, .018 and .029). Pairwise comparisons showed that physicians’ educational levels in Southern Jiangsu and Central Jiangsu were significantly higher than in Northern Jiangsu ( χ 2 = 9.452 and 6.984; both P = .006). The annual number of examinations in Central Jiangsu exceeded that in Southern Jiangsu ( P = .015). The physician-to-patient ratio in Southern Jiangsu was higher than in Central Jiangsu ( P = .010). Northern Jiangsu reported more critical-value notifications than Southern Jiangsu ( P = .004). Diagnostic concordance rate in Southern Jiangsu was higher than in Northern Jiangsu ( P = .009). Significant interregional disparities in ultrasound quality control exist in Jiangsu’s healthcare institutions. Targeted workforce development, optimized facility allocation, quality-control systems, and collaboration are needed to enhance diagnostic safety, equity, and outcomes.
- 5 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (23) , e49181
Open AccessAnalysis of ultrasound quality control in primary healthcare institutions: A cross-sectional study from Jiangsu Province, China
Ultrasound is integral to modern clinical care, but primary healthcare institutions often face equipment, staffing, and quality-control challenges that produce inconsistent imaging and undermine diagnostic reliability. This study evaluated interregional differences in ultrasound quality control across Jiangsu Province to inform resource allocation and policy. This study aimed to analyze the current status of ultrasound quality control in primary healthcare institutions across different regions of Jiangsu Province. We conducted province-wide ultrasound quality-control management using a targeted electronic instrument, The Jiangsu Provincial Survey Questionnaire on Ultrasound Medical Quality Control in Primary Healthcare Institutions. A random sample of 61 primary-care ultrasound departments was surveyed. Seven indicators were analyzed: staffing, number of ultrasound examinations, physician-to-patient ratio, ratio of ultrasound physicians to diagnostic devices, number of critical-value notifications, positive rate of ultrasound reports, and diagnostic concordance rate. Between-group comparisons employed 1-way analysis of variance or Kruskal–Wallis tests according to normality and variance homogeneity; categorical variables were compared using χ 2 tests, with significance at.05. No statistically significant regional differences were observed for the number of ultrasound physicians, number of sonographers (technologists), sonographers’ educational attainment, the ratio of physicians to ultrasound diagnostic devices, or the positive rate of ultrasound reports. Significant differences were found for physicians’ educational attainment ( χ 2 = 13.554, P = .006) and for annual number of examinations ( F = 3.171, P = .049). Significant regional differences in physician-to-patient ratio, number of critical-value notifications, and diagnostic concordance rate ( H = 6.982, 8.170 and 7.061; P = .030, .018 and .029). Pairwise comparisons showed that physicians’ educational levels in Southern Jiangsu and Central Jiangsu were significantly higher than in Northern Jiangsu ( χ 2 = 9.452 and 6.984; both P = .006). The annual number of examinations in Central Jiangsu exceeded that in Southern Jiangsu ( P = .015). The physician-to-patient ratio in Southern Jiangsu was higher than in Central Jiangsu ( P = .010). Northern Jiangsu reported more critical-value notifications than Southern Jiangsu ( P = .004). Diagnostic concordance rate in Southern Jiangsu was higher than in Northern Jiangsu ( P = .009). Significant interregional disparities in ultrasound quality control exist in Jiangsu’s healthcare institutions. Targeted workforce development, optimized facility allocation, quality-control systems, and collaboration are needed to enhance diagnostic safety, equity, and outcomes.
- Open Access
- 18 January 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 164, 108408
Washed microbiota transplantation as salvage therapy for antibiotic-resistant Salmonella infection in two pediatric patients
- 18 January 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 164, 108408
Open AccessWashed microbiota transplantation as salvage therapy for antibiotic-resistant Salmonella infection in two pediatric patients
- Open Access
- 17 November 2025
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 12, 1704157
A prognostic nomogram for predicting overall survival in gastric signet ring cell carcinoma patients: a SEER database and Chinese registry analysis
Purpose: Gastric signet ring cell carcinoma (GSRC) is a distinct gastric cancer (GC) subtype. This study aimed to develop and validate a nomogram to predict overall survival (OS) and guide clinical decision-making. Methods: This study included 2,203 GSRC patients from the SEER database (2010–2019), randomly split into a modeling cohort (n = 1,542) and an internal validation cohort (n = 661). An external cohort of 74 patients from the Second Affiliated Hospital of Nanjing Medical University (2019–2024; median follow-up 34 months) was used for validation. Predictor variables—age, sex, chemotherapy, lymph node ratio (LNR), T and M categories, tumor size, and tumor number—were included in a cox proportional hazard model. A nomogram was derived from the cox model and internally validated using 1,000 bootstrap resamples. Discrimination, calibration, and decision curve analysis (DCA) evaluated model performance. Results: The nomogram included age, chemotherapy, LNR, T and M categories, and tumor size. In the modeling cohort, time-dependent area under the receiver operating characteristic curve (AUC) was 0.79, 0.85, and 0.85 at 12, 36, and 60 months; internal validation AUCs were 0.79, 0.85, and 0.85. In the external cohort, AUC at 36 months was 0.91 (primary horizon), with exploratory IPCW-AUCs of 1.00 at 12 and 60 months due to class imbalance. Calibration showed close agreement between predicted and observed OS, and DCA demonstrated clinical net benefit across relevant thresholds. Conclusion: This study developed a nomogram for OS prediction in GSRC patients, supporting risk stratification and clinical decision-making.
- 17 November 2025
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 12, 1704157
Open AccessA prognostic nomogram for predicting overall survival in gastric signet ring cell carcinoma patients: a SEER database and Chinese registry analysis
Purpose: Gastric signet ring cell carcinoma (GSRC) is a distinct gastric cancer (GC) subtype. This study aimed to develop and validate a nomogram to predict overall survival (OS) and guide clinical decision-making. Methods: This study included 2,203 GSRC patients from the SEER database (2010–2019), randomly split into a modeling cohort (n = 1,542) and an internal validation cohort (n = 661). An external cohort of 74 patients from the Second Affiliated Hospital of Nanjing Medical University (2019–2024; median follow-up 34 months) was used for validation. Predictor variables—age, sex, chemotherapy, lymph node ratio (LNR), T and M categories, tumor size, and tumor number—were included in a cox proportional hazard model. A nomogram was derived from the cox model and internally validated using 1,000 bootstrap resamples. Discrimination, calibration, and decision curve analysis (DCA) evaluated model performance. Results: The nomogram included age, chemotherapy, LNR, T and M categories, and tumor size. In the modeling cohort, time-dependent area under the receiver operating characteristic curve (AUC) was 0.79, 0.85, and 0.85 at 12, 36, and 60 months; internal validation AUCs were 0.79, 0.85, and 0.85. In the external cohort, AUC at 36 months was 0.91 (primary horizon), with exploratory IPCW-AUCs of 1.00 at 12 and 60 months due to class imbalance. Calibration showed close agreement between predicted and observed OS, and DCA demonstrated clinical net benefit across relevant thresholds. Conclusion: This study developed a nomogram for OS prediction in GSRC patients, supporting risk stratification and clinical decision-making.
- Open Access
- 27 May 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1586308
Bibliometric mapping of diabetes mellitus and sarcopenia research: hotspots and emerging trends
Background: Diabetes mellitus and sarcopenia are chronic metabolic disorders characterized by bidirectional interactions, frequently coexisting as comorbidities whose interrelationship has garnered increasing scientific attention. This study pioneers a bibliometric analysis to systematically investigate their association, aiming to map the knowledge structure, evolutionary trajectories, current foci, and emerging frontiers within this area.Methods: We retrieved 2,773 publications from the Web of Science Core Collection from inception until December 26, 2024, and visual analyses were conducted using CiteSpace, VOSviewer, R, and Microsoft Excel. The analysis characterized disciplinary distributions, publication outputs, national/regional contributions, institutional collaborations, authorship networks, journal profiles, references, and keywords.Results: Annual publications demonstrated sustained growth, with the United States dominating scholarly contributions. Research exhibited marked interdisciplinary integration, although investigations linking type 1 diabetes mellitus with sarcopenia remain limited. Current research hotspots included shared pathological mechanisms such as insulin resistance and chronic inflammation, clinical characterization of specific subtypes such as sarcopenic obesity, imaging-based assessment of muscle dysfunction in diabetes, and the therapeutic efficacy of exercise as an intervention. Mechanistic exploration was determined to be the primary driver of domain advancement.Conclusion: The field has evolved from theoretical frameworks to clinical applications, highlighting the importance of uncovering common pathophysiological mechanisms and pinpointing potential therapeutic targets. Future priorities include refining screening and diagnostic protocols, optimizing preventive strategies, and developing personalized interventions. Cross-disciplinary innovations integrating multi-omics and precision medicine are poised to reshape this research landscape.
- 27 May 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1586308
Open AccessBibliometric mapping of diabetes mellitus and sarcopenia research: hotspots and emerging trends
Background: Diabetes mellitus and sarcopenia are chronic metabolic disorders characterized by bidirectional interactions, frequently coexisting as comorbidities whose interrelationship has garnered increasing scientific attention. This study pioneers a bibliometric analysis to systematically investigate their association, aiming to map the knowledge structure, evolutionary trajectories, current foci, and emerging frontiers within this area.Methods: We retrieved 2,773 publications from the Web of Science Core Collection from inception until December 26, 2024, and visual analyses were conducted using CiteSpace, VOSviewer, R, and Microsoft Excel. The analysis characterized disciplinary distributions, publication outputs, national/regional contributions, institutional collaborations, authorship networks, journal profiles, references, and keywords.Results: Annual publications demonstrated sustained growth, with the United States dominating scholarly contributions. Research exhibited marked interdisciplinary integration, although investigations linking type 1 diabetes mellitus with sarcopenia remain limited. Current research hotspots included shared pathological mechanisms such as insulin resistance and chronic inflammation, clinical characterization of specific subtypes such as sarcopenic obesity, imaging-based assessment of muscle dysfunction in diabetes, and the therapeutic efficacy of exercise as an intervention. Mechanistic exploration was determined to be the primary driver of domain advancement.Conclusion: The field has evolved from theoretical frameworks to clinical applications, highlighting the importance of uncovering common pathophysiological mechanisms and pinpointing potential therapeutic targets. Future priorities include refining screening and diagnostic protocols, optimizing preventive strategies, and developing personalized interventions. Cross-disciplinary innovations integrating multi-omics and precision medicine are poised to reshape this research landscape.
- Open Access
- 1 January 2025
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 39 (4) , 430-5
Washed microbiota transplantation effectively treats a case of acute severe ulcerative colitis combined with viral myocarditis
Viral myocarditis is a rare but life-threatening complication in patients with ulcerative colitis (UC). Management of myocarditis is primarily supportive, as there are currently no established targeted therapies. Recent studies have increasingly demonstrated the association between gut microbiota and myocarditis. Here, we report a case of acute severe UC complicated by cytomegalovirus (CMV) and Epstein-Barr virus (EBV) co-infections leading to viral myocarditis. The patient experienced rapid remission of both intestinal and cardiac symptoms following washed microbiota transplantation (WMT), suggesting WMT as a potential alternative treatment for these life-threatening conditions.
- 1 January 2025
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 39 (4) , 430-5
Open AccessWashed microbiota transplantation effectively treats a case of acute severe ulcerative colitis combined with viral myocarditis
Viral myocarditis is a rare but life-threatening complication in patients with ulcerative colitis (UC). Management of myocarditis is primarily supportive, as there are currently no established targeted therapies. Recent studies have increasingly demonstrated the association between gut microbiota and myocarditis. Here, we report a case of acute severe UC complicated by cytomegalovirus (CMV) and Epstein-Barr virus (EBV) co-infections leading to viral myocarditis. The patient experienced rapid remission of both intestinal and cardiac symptoms following washed microbiota transplantation (WMT), suggesting WMT as a potential alternative treatment for these life-threatening conditions.
- Open Access
- 22 April 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-11
Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation
Background: Colorectal signet-ring cell carcinoma (SRCC) is a rare cancer with a bleak prognosis. The relationship between its clinicopathological features and survival remains incompletely elucidated. Tumor deposits (TD) have been utilized to guide the N staging in the 8th edition of American Joint Committee on Cancer (AJCC) staging manual, but their prognostic significance remains to be established in colorectal SRCC. Patients and methods: The subjects of this study were patients with stage III/IV colorectal SRCC who underwent surgical treatment. The research comprised two cohorts: a training cohort and a validation cohort. The training cohort consisted of 631 qualified patients from the SEER database, while the validation cohort included 135 eligible patients from four independent hospitals in China. The study assessed the impact of TD on Cancer-Specific Survival (CSS) and Overall Survival (OS) using Kaplan-Meier survival curves and Cox regression models. Additionally, a prognostic nomogram model was constructed for further evaluation. Results: In both cohorts, TD-positive patients were typically in the stage IV and exhibited the presence of perineural invasion (PNI) (P < 0.05). Compared to the TD-negative group, the TD-positive group showed significantly poorer CSS (the training cohort: HR, 1.87; 95% CI, 1.52–2.31; the validation cohort: HR, 2.43; 95% CI, 1.55–3.81; all P values < 0.001). This association was significant in stage III but not in stage IV. In the multivariate model, after adjusting for covariates, TD maintained an independent prognostic value (P < 0.05). A nomogram model including TD, N stage, T stage, TNM stage, CEA, and chemotherapy was constructed. Through internal and external validation, the model demonstrated good calibration and accuracy. Further survival curve analysis based on individual scores from the model showed good discrimination. Conclusion: TD positivity is an independent factor of poor prognosis in colorectal SRCC patients, and it is more effective to predict the prognosis of colorectal SRCC by building a model with TD and other clinically related variables.
- 22 April 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-11
Open AccessPrognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation
Background: Colorectal signet-ring cell carcinoma (SRCC) is a rare cancer with a bleak prognosis. The relationship between its clinicopathological features and survival remains incompletely elucidated. Tumor deposits (TD) have been utilized to guide the N staging in the 8th edition of American Joint Committee on Cancer (AJCC) staging manual, but their prognostic significance remains to be established in colorectal SRCC. Patients and methods: The subjects of this study were patients with stage III/IV colorectal SRCC who underwent surgical treatment. The research comprised two cohorts: a training cohort and a validation cohort. The training cohort consisted of 631 qualified patients from the SEER database, while the validation cohort included 135 eligible patients from four independent hospitals in China. The study assessed the impact of TD on Cancer-Specific Survival (CSS) and Overall Survival (OS) using Kaplan-Meier survival curves and Cox regression models. Additionally, a prognostic nomogram model was constructed for further evaluation. Results: In both cohorts, TD-positive patients were typically in the stage IV and exhibited the presence of perineural invasion (PNI) (P < 0.05). Compared to the TD-negative group, the TD-positive group showed significantly poorer CSS (the training cohort: HR, 1.87; 95% CI, 1.52–2.31; the validation cohort: HR, 2.43; 95% CI, 1.55–3.81; all P values < 0.001). This association was significant in stage III but not in stage IV. In the multivariate model, after adjusting for covariates, TD maintained an independent prognostic value (P < 0.05). A nomogram model including TD, N stage, T stage, TNM stage, CEA, and chemotherapy was constructed. Through internal and external validation, the model demonstrated good calibration and accuracy. Further survival curve analysis based on individual scores from the model showed good discrimination. Conclusion: TD positivity is an independent factor of poor prognosis in colorectal SRCC patients, and it is more effective to predict the prognosis of colorectal SRCC by building a model with TD and other clinically related variables.